Mother-infant transfer of anti-human papillomavirus (HPV) antibodies following vaccination with the quadrivalent HPV (type 6/11/16/18) virus-like particle vaccine

by Katie Matys, Sara Mallary, Oliver Bautista, Scott Vuocolo, Ricardo Manalastas, Punee Pitisuttithum, Alfred Saah
Published 2018

Long-term immunogenicity, effectiveness, and safety of nine-valent human papillomavirus vaccine in girls and boys 9 to 15 years of age: Interim analysis after 8 years of follow-up

by Sven Eric Olsson, Jaime Alberto Restrepo, Julio Cesar Reina, Punnee Pitisuttithum, Angels Ulied, Meera Varman, Pierre Van Damme, Edson Duarte Moreira, Daron Ferris, Stanley Block, Oliver Bautista, Nancy Gallagher, Jennifer McCauley, Alain Luxembourg
Published 2020

Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial

by Nubia Muñoz, Ricardo Manalastas, Punee Pitisuttithum, Damrong Tresukosol, Joseph Monsonego, Kevin Ault, Christine Clavel, Joaquin Luna, Evan Myers, Sara Hood, Oliver Bautista, Janine Bryan, Frank J. Taddeo, Mark T. Esser, Scott Vuocolo, Richard M. Haupt, Eliav Barr, Alfred Saah
Published 2018

Three-year follow-up of 2-dose versus 3-dose HPV vaccine

by Jacob Bornstein, Surita Roux, Lone Kjeld Petersen, Li Min Huang, Simon R. Dobson, Punnee Pitisuttithum, Javier Diez-Domingo, Andrea Schilling, Hany Ariffin, Richard Tytus, Richard Rupp, Shelly Senders, Eli Engel, Daron Ferris, Yae Jean Kim, Young Tae Kim, Zafer Kurugol, Oliver Bautista, Katrina M. Nolan, Sandhya Sankaranarayanan, Alfred Saah, Alain Luxembourg
Published 2022